ArticleRapid communications in mass spectrometry : RCM2025

Validation of ion mobility spectrometry - mass spectrometry as a screening tool to identify type II kinase inhibitors of FGFR1 kinase.

Helen S Beeston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.